4.7 Article

Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: Iontophoresis further enhances drug delivery ex vivo

Journal

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 154, Issue -, Pages 1265-1275

Publisher

ELSEVIER
DOI: 10.1016/j.ijbiomac.2019.11.001

Keywords

Mucoadhesion; Oral cancer; Topical delivery

Funding

  1. Coordination for Higher Education Personnel Improvement - CAPES (Brazil)
  2. National Council for Research and Development - CNPq [470272/2013-9]
  3. DPP/FUB/UnB [Edital 01/2013]
  4. Research Support Foundation of the Federal District - FAP-DF [193.000.208/2014]

Ask authors/readers for more resources

Tumors located in the oral mucosa are challenging to treat since surgery can lead to aesthetic, speech, and salivation problems, radiotherapy alone is often ineffective, and systemic chemotherapy brings meaningful side effects to the patient. Here, we proposed to develop mucoadhesive chitosan nanoparticles entrapping the chemotherapeutic oxaliplatin (OXPt) and to evaluate ex vivo its penetration in porcine mucosa under both passive and iontophoretic topical treatments. OXPt-loaded chitosan nanoparticles presented a small hydrodynamic size (188 +/- 20 nm), narrow distribution (PDI of 0.28 +/- 0.02) and positive zeta potential (+44.8 +/- 2.8 mV). These nanoparticles provided a burst effect on drug release followed by a longer-term controlled release. When applied to the oral mucosa, the chitosan nanoparticles increased 3-fold drug penetration, and this rate was maintained even when the mucosa was washed with a buffer to mimic salivation. Iontophoresis doubled the amount of OXPt transported to the mucosa. These amounts exceeded the dose required to cause cell death of an oral tumor cell line. Besides, chitosan nanoparticles increased the rate of cells that entered into apoptosis. In summary, this study points to the feasibility of topical therapy with chitosan nanoparticles, potentialized by the application of iontophoresis, to treat oral tumors. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available